Status:
COMPLETED
Apneic Oxygenation in the Pediatric Intensive Care Unit
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Intubation Complication
Eligibility:
All Genders
Up to 17 years
Phase:
NA
Brief Summary
The purpose of the study is to determine the impact of apneic oxygenation on the time to desaturation in pediatric patients treated in a pediatric intensive care unit (PICU). The investigators hypothe...
Detailed Description
Oxygen (O2) desaturation is one of the risks of intubation, especially in critically ill children with comorbidities, increased O2 consumption and decreased O2 delivery. Desaturation places patients a...
Eligibility Criteria
Inclusion
- Treated in the PICU at ACH-PR
- Age 0 through17 years
- Indication for emergent intubation
- Premedication with a paralytic agent resulting in apnea
Exclusion
- No paralytic agent used
- Elective intubations
- Presence of cyanotic heart disease
- Inability to safely place nasal cannula on patient
- Nasal intubation
- Patients already enrolled in the study (prior intubation)
- Inability to randomize due to urgency of intubation
- Females who are known to be pregnant
Key Trial Info
Start Date :
December 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03374046
Start Date
December 23 2017
End Date
February 1 2020
Last Update
October 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advocate Lutheran General Hospital
Park Ridge, Illinois, United States, 60068